Patient’s choice of observational strategy for early-stage prostate cancer

Active Surveillance (AS) may represent for selected patients with low risk, potentially indolent prostate cancer (PCa) a viable alternative to radical therapies, thus reducing the risk of over-treatment. Researchers and clinicians emphasized that the choice of AS may be a controversial one as patients have the chance to avoid the side effects of radical therapies but also the burden of living with an untreated PCa. The aim of our study is to...